Skip to content
(RS)-tegafur

Structure via PubChem · Public domain (PubChem)

EntityQ413370· pop 15· linked from 312 articles

(RS)-tegafur

Sign in to save

Also known as MJF-12264, 1-(2-tetrahydrofuryl)-5-fluorouracil, tegafur

Tegafur is a chemotherapeutic prodrug of 5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug tegafur/uracil. When metabolised, it becomes 5-FU.

Chemical data

Formula
C8H9FN2O3
Molecular weight
200.17 g/mol
IUPAC name
5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione
SMILES
C1CC(OC1)N2C=C(C(=O)NC2=O)F
InChIKey
WFWLQNSHRPWKFK-UHFFFAOYSA-N
XLogP
-0.3
Polar surface area
58.6 Ų
H-bond donors
1
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
Indications
neoplasm, head and neck squamous cell carcinoma, hepatocellular carcinoma, colorectal adenocarcinoma

via ChEMBL · EBI

Wikidata facts

Subclass of
medication
Mass
200.05972
Show 6 more facts
chemical formula
C₈H₉FN₂O₃
route of administration
topical medication
World Health Organisation international non-proprietary name
tegafur
canonical SMILES
C1CC(OC1)N2C=C(C(=O)NC2=O)F
Commons category
Tegafur
significant drug interaction
acenocoumarol
Sources (3)

via Wikidata · CC0

~2 min read

Encyclopedic overview

8 sections
Contents
  • Medical uses
  • Adverse effects
  • Pharmacogenetics
  • Mechanism of action
  • Pharmacokinetics
  • Interactive pathway map
  • See also
  • References

Tegafur is a chemotherapeutic prodrug of 5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug tegafur/uracil. When metabolised, it becomes 5-FU.

It was patented in 1967 and approved for medical use in 1972.

Excerpted from Wikipedia’s “(RS)-tegafur” article, available under the CC BY-SA 4.0 licence.